Free Essays,College Free Essays,Free College Essays at Anti Essays

Problem Solution: Gene One
In 1996, Gene One entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals. This has turned Gene One from a $2 million company to a $400 million company in just eight short years. Gene One has decided to take the leap and take the company public. The interest was caused primary by the rising stock on Wall Street indicating strong growth and interest in the biotechnology industry. The idea was strengthen by the leadership change at the Food and Drug Administration which enhanced investor confidence in the industry. The CEO believes that in order to keep up the pace with demand also to realize modest annual growth targets of 40% in 36 months, Gene One must seize this opportunity by going public within the next three years. The timing seems to be right and the idea of the company being able to obtain much needed IPO capital for new development, advertisement, and marketing if Gene One is to remain successful.
Situation Analysis
Issue and Opportunity Identification
The issues surrounding Gene One efforts of obtain IPO status therefore; taking the private company public has been sparked by the CEO convincing the Board members to go public. This will allow Gene One the ability to keep pace with the demand of the biotech industry and realize conservative annual growth of 40% by going public within the next three years. Gene One assumes that the time is right, but the company reason is the need for IPO capital for new development, advertisement, and marketing if Gene One is to remain successful. A few of the issues that Gene One faces are with its Executive Board members, the Senior Leadership team and the current associates of the company.
Gene One’s Board members have made the decision...